Latest Asx News

Condor Energy has agreed to acquire Jaguar Exploration’s 20% stake in the TEA 86 offshore Peru project, moving to full ownership. The deal, structured through performance shares, aims to simplify equity and support licence conversion and future partnerships.

Exultant Mining Limited (ASX:10X) has identified several compelling geophysical anomalies at its Peak View Prospect in New South Wales, setting the stage for a maiden drilling campaign planned for late April 2026.

Electro Optic Systems Holdings Limited (ASX: EOS) has concluded its civil penalty proceedings with ASIC, agreeing to a $4 million penalty and costs. This resolution marks a significant step in addressing legacy issues and refocusing on strategic growth.

De.mem Limited has responded to an ASX query regarding the late lodgement of an Appendix 3Y for director Andreas Hendrik De Wit, attributing the delay to an administrative oversight. The company has outlined existing compliance protocols and introduced additional measures to prevent future lapses.

Identitii Limited has secured $200,000 through a placement of approximately 28.57 million shares at $0.007 each to existing shareholders, including Cameron Beavis, to address short-term funding needs while adhering to Takeovers Panel orders related to its Rights Issue.

Regener8 Resources NL Ltd (ASX:R8R) has revised its pro rata non-renounceable rights issue, offering new shares at $0.10 each to eligible shareholders across five jurisdictions. The offer aims to raise up to $2.87 million before costs, with further details due in early April.

Eastern Gas Corporation Limited has addressed ASX concerns regarding trading by a non-executive director and a related entity during a closed period, outlining remedial actions and governance reviews.

Critical Resources Limited has initiated ground exploration at its Lammerlaw and Croesus projects in New Zealand, focusing on historically significant gold, antimony, and tungsten mineralisation. The company highlights exceptional historic tungsten grades up to 42.6% WO3 and a multi-kilometre gold-antimony trend, with initial results expected in the coming months.

Mesoblast Limited (ASX:MSB, Nasdaq:MESO) has received FDA Investigational New Drug clearance to initiate a pivotal clinical trial of its cell therapy Ryoncil in children with Duchenne Muscular Dystrophy, aiming to address inflammation-driven disease progression.

Insignia Financial has received Foreign Investment Review Board approval for its proposed acquisition by Daintree BidCo, clearing a key regulatory hurdle. The scheme now awaits shareholder and court approvals, with the board recommending shareholder support.

Tamboran Resources Corporation has initiated a significant equity raise totaling approximately US$198 million to fund expanded drilling and development activities in the Beetaloo Basin. The capital raise includes a registered underwritten public offering and a pro rata entitlement offer, representing a 25% increase in shares on issue.

Tamboran Resources Corporation has initiated an underwritten public offering of nearly 3 million shares to support expanded drilling and resource delineation in the Beetaloo Basin, alongside a concurrent institutional entitlement offer.